Eternal Peptides MOTS-C 10mg Peptide

MOTS-C 10mg is a laboratory research peptide supplied by Eternal Peptides in a 10mg lyophilized vial format. Rather than presenting the compound as a consumer wellness product, the appropriate framing is analytical: identity, peptide characteristics, batch traceability, purity documentation, storage conditions, and laboratory handling are the relevant decision points. Eternal Peptides states that its MOTS-C is independently third-party tested, verified at ≥99% purity, and supported by lot-specific Certificates of Analysis. For research teams comparing peptide materials, this product is intended solely for lawful laboratory investigation and is explicitly not for human, veterinary, diagnostic, therapeutic, household, or consumptive use.

The Science of MOTS-C 10mg Research Characterization

MOTS-C is described by the supplier as a mitochondrial-derived peptide composed of 16 amino acids, with the sequence MRWQEMGYIFYPRKRR and an approximate molecular weight of 2,117 Da. In a research-product context, quality assessment depends less on speculative outcome claims and more on verifiable material characteristics and handling controls.

Identity Verification: Lot-specific analytical documentation is used to confirm that the material corresponds to the labeled peptide. The supplier states that identity may be documented through HPLC and/or mass spectrometry within the COA framework.

Purity Documentation: Eternal Peptides states a minimum purity of ≥99% for MOTS-C. Researchers should match the received batch identifier to the corresponding lot-specific COA rather than relying on a generic purity statement alone.

Physical Research Format: The peptide is supplied lyophilized in a glass vial. This format is designed for controlled laboratory storage and subsequent preparation according to institutional protocols and appropriate research procedures.

Key Benefits of Eternal Peptides MOTS-C 10mg

Specifications

Usage Guide

This material should be handled only within an appropriate laboratory environment by qualified research personnel. Keep the lyophilized vial protected from light and moisture and follow the supplier's stated storage range together with institutional biosafety requirements. If a working solution is required for an approved research protocol, use a suitable sterile reconstitution solution or laboratory-grade buffer and follow the protocol's validated preparation method. Avoid unnecessary freeze-thaw cycling of prepared solutions; aliquoting may be appropriate where the research protocol supports it. Always defer to the lot-specific COA, institutional procedures, and applicable laws.

Safety Information

Eternal Peptides states that MOTS-C 10mg is strictly for laboratory research use only. It is not approved for human or veterinary use and must not be administered, consumed, prescribed, used diagnostically, or presented as a therapeutic product. The supplier also states that human safety, efficacy, and pharmacological profiles have not been established. Laboratory personnel should use appropriate institutional handling controls, personal protective equipment, contamination-prevention procedures, storage practices, and waste-disposal protocols. Access should be restricted to authorized research personnel. Purchasers are responsible for compliance with local laws, research-use regulations, and institutional biosafety requirements.

Frequently Asked Questions

What makes this MOTS-C 10mg format different?

It is supplied as a 10mg lyophilized peptide in a glass vial and is positioned by the supplier as a research-only material with lot-specific third-party COA support.

What quality information is provided for this product?

The brand states ≥99% purity and describes third-party testing for identity and purity, with additional testing such as sterility, endotoxin, and heavy metals available depending on the lot and report.

How should MOTS-C 10mg be integrated into a laboratory workflow?

Use it only within a lawful, documented research protocol. Storage, preparation, reconstitution, aliquoting, and analytical use should follow the lot documentation, validated laboratory methods, and institutional biosafety procedures.

How long before a research team obtains practical value from the material?

That depends on the experimental design, analytical method, controls, endpoints, and validation plan. The product page does not establish any timeline for biological or clinical outcomes.